Network Reconstruction and Significant Pathway Extraction Using Phosphoproteomic Data from Cancer Cells

Protein phosphorylation acts as an efficient switch controlling deregulated key signaling pathway in cancer. Computational biology aims to address the complexity of reconstructed networks but overrepresents well‐known proteins and lacks information on less‐studied proteins. A bioinformatic tool to reconstruct and select relatively small networks that connect signaling proteins to their targets in specific contexts is developed. It enables to propose and validate new signaling axes of the Syk kinase. To validate the potency of the tool, it is applied to two phosphoproteomic studies on oncogenic mutants of the well‐known phosphatidyl‐inositol 3‐kinase (PIK3CA) and the unfamiliar Src‐related tyrosine kinase lacking C‐terminal regulatory tyrosine and N‐terminal myristoylation sites (SRMS) kinase. By combining network reconstruction and signal propagation, comprehensive signaling networks from large‐scale experimental data are built and multiple molecular paths from these kinases to their targets are extracted. Specific paths from two distinct PIK3CA mutants are retrieved, and their differential impact on the HER3 receptor kinase is explained. In addition, to address the missing connectivities of the SRMS kinase to its targets in interaction pathway databases, phospho‐tyrosine and phospho‐serine/threonine proteomic data are integrated. The resulting SRMS‐signaling network comprises casein kinase 2, thereby validating its currently suggested role downstream of SRMS. The computational pipeline is publicly available, and contains a user‐friendly graphical interface (http://doi.org/10.5281/zenodo.3333687).

[1]  B. Park,et al.  Mutation of the PIK3CA oncogene in human cancers , 2006, British Journal of Cancer.

[2]  K. Lukong,et al.  Phosphoproteomics Analysis Identifies Novel Candidate Substrates of the Nonreceptor Tyrosine Kinase, Src-related Kinase Lacking C-terminal Regulatory Tyrosine and N-terminal Myristoylation Sites (SRMS) * , 2018, Molecular & Cellular Proteomics.

[3]  Prahlad T. Ram,et al.  NetWalker: a contextual network analysis tool for functional genomics , 2012, BMC Genomics.

[4]  A. Pandey,et al.  A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutations , 2015, Proteomics.

[5]  Hiroyuki Konishi,et al.  The PIK3CA gene is mutated with high frequency in human breast cancers , 2004, Cancer biology & therapy.

[6]  Aurélien Naldi,et al.  Reconstruction and signal propagation analysis of the Syk signaling network in breast cancer cells , 2017, PLoS Comput. Biol..

[7]  Y. Yun,et al.  Discovery of gastric cancer specific biomarkers by the application of serum proteomics , 2017, Proteomics.

[8]  S. Pervaiz,et al.  Casein Kinase II: an attractive target for anti-cancer drug design. , 2010, The international journal of biochemistry & cell biology.

[9]  Michael A. White,et al.  Use of Data-Biased Random Walks on Graphs for the Retrieval of Context-Specific Networks from Genomic Data , 2010, PLoS Comput. Biol..

[10]  P. Vogt,et al.  Cancer-specific mutations in PIK3CA are oncogenic in vivo , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Joon-Oh Park,et al.  MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling , 2007, Science.

[12]  David J. Lynn,et al.  DyNet: visualization and analysis of dynamic molecular interaction networks , 2016, Bioinform..

[13]  M. Le Borgne,et al.  Topology and static response of interaction networks in molecular biology , 2006, Journal of The Royal Society Interface.

[14]  T. Yagi,et al.  A novel nonreceptor tyrosine kinase, Srm: cloning and targeted disruption , 1994, Molecular and cellular biology.

[15]  Minoru Kanehisa,et al.  KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..

[16]  Eduardo Sontag,et al.  Untangling the wires: A strategy to trace functional interactions in signaling and gene networks , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Minoru Kanehisa,et al.  New approach for understanding genome variations in KEGG , 2018, Nucleic Acids Res..

[18]  Gary D. Bader,et al.  Pathway Commons, a web resource for biological pathway data , 2010, Nucleic Acids Res..

[19]  Bin Zhang,et al.  PhosphoSitePlus, 2014: mutations, PTMs and recalibrations , 2014, Nucleic Acids Res..

[20]  A. Rivett,et al.  Phosphorylation of 20S proteasome alpha subunit C8 (alpha7) stabilizes the 26S proteasome and plays a role in the regulation of proteasome complexes by gamma-interferon. , 2004, The Biochemical journal.

[21]  Romain M. Larive,et al.  Phosphoproteomic analysis of Syk kinase signaling in human cancer cells reveals its role in cell–cell adhesion , 2009, Oncogene.

[22]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[23]  K. Lukong,et al.  The unique N‐terminal region of SRMS regulates enzymatic activity and phosphorylation of its novel substrate docking protein 1 , 2013, The FEBS journal.

[24]  K. Lukong,et al.  Global phosphoproteomic analysis identifies SRMS-regulated secondary signaling intermediates , 2018, Proteome Science.

[25]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[26]  Anna Ritz,et al.  Pathways on demand: automated reconstruction of human signaling networks , 2016, npj Systems Biology and Applications.